Concurrent Nimotuzumab in Chemoradiation of Advanced Inoperable Head & Neck Cancer

Click here to view Slideshow


-Radiation therapy is the primary modality of treatment for loco-regionally advanced inoperable Head & Neck cancers
With Radiation therapy alone the rate of treatment failure is high, the overall cure rate and length of patient survival is lower. 

-New strategies have been continuously implemented : 
Use of concurrent chemotherapeutic drugs as radiation sensitizers has perhaps had the strongest impact on radiation therapy practice.

-Currently Biological response modifiers which enhance radiation and chemotherapy responses have been shown to further improve the therapeutic outcome of radiation therapy with acceptable morbidity.